A detailed history of Trexquant Investment LP transactions in Biote Corp. stock. As of the latest transaction made, Trexquant Investment LP holds 120,544 shares of BTMD stock, worth $417,082. This represents 0.01% of its overall portfolio holdings.

Number of Shares
120,544
Previous 101,757 18.46%
Holding current value
$417,082
Previous $636,000 36.95%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025

BUY
$3.23 - $6.2 $60,682 - $116,479
18,787 Added 18.46%
120,544 $401,000
Q4 2024

Feb 12, 2025

BUY
$5.04 - $6.93 $414,807 - $570,359
82,303 Added 423.06%
101,757 $636,000
Q3 2024

Nov 12, 2024

SELL
$5.33 - $8.36 $143,126 - $224,491
-26,853 Reduced 57.99%
19,454 $108,000
Q2 2024

Aug 13, 2024

BUY
$5.44 - $7.47 $251,910 - $345,913
46,307 New
46,307 $345,000
Q3 2023

Nov 13, 2023

BUY
$4.73 - $7.83 $91,478 - $151,432
19,340 New
19,340 $99,000

Others Institutions Holding BTMD

About biote Corp.


  • Ticker BTMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 7,574,270
  • Market Cap $26.2M
  • Description
  • biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...
More about BTMD
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.